Synthaverse S.A. (WSE:SVE)
Poland · Delayed Price · Currency is PLN 2.600
-0.010 (-0.38%)
Nov 4, 2026, 12:58 PM CET
Synthaverse Market Cap
Synthaverse has a market cap or net worth of 197.65 million as of November 3, 2026. It is the 29,874th most valuable company in the world and the 196th biggest in Poland. Its market cap has decreased by 31.04% in one year.
Market Cap
197.65M
Enterprise Value
280.56M
Revenue
48.76M
Global Rank
Country Rank
#196 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since July 29, 2011, Synthaverse's market cap has increased from 144.00M to 197.65M, an increase of 37.26%. That is a compound annual growth rate of 2.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 197.65M | -23.48% |
| Dec 30, 2025 | 258.31M | -18.67% |
| Dec 30, 2024 | 317.63M | 5.87% |
| Dec 29, 2023 | 300.01M | -28.71% |
| Dec 30, 2022 | 420.86M | 45.25% |
| Dec 30, 2021 | 289.76M | -48.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 527.59M |
| Ryvu Therapeutics | 392.58M |
| Bioceltix | 387.26M |
| Captor Therapeutics Spolka Akcyjna | 336.73M |
| BIOTON | 291.94M |
| Mabion | 127.68M |
| Poltreg | 126.02M |
| Molecure | 119.09M |